Capturing adaptive immunity against SARS-CoV-2 in patients with cancer

被引：0
|
作者：
Hendrik Luxenburger
Robert Thimme
机构：
[1] Freiburg University Medical Center,Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases)
[2] Faculty of Medicine,IMM
[3] University of Freiburg,PACT, Faculty of Medicine
[4] University of Freiburg,undefined
来源：
Nature Cancer | 2021年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer is associated with higher risk of severe COVID-19 outcomes. Two studies prospectively analyze the immunological and clinical characteristics of a large cohort of patients with cancer following SARS-CoV-2 infection or vaccination, providing important clinical insights to improve the management of such vulnerable patients.
引用
收藏
页码：1298 / 1300
页数：2
相关论文
共 50 条
  • [41] Innate immunity: the first line of defense against SARS-CoV-2
    Diamond, Michael S.
    Kanneganti, Thirumala-Devi
    NATURE IMMUNOLOGY, 2022, 23 (02) : 165 - 176
  • [42] Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
    Alessio Cortellini
    Juan Aguilar-Company
    Ramon Salazar
    Mark Bower
    Ailsa Sita-Lumsden
    Andrea Plaja
    Alvin J. X. Lee
    Alexia Bertuzzi
    Carlo Tondini
    Nikolaos Diamantis
    Clara Martinez-Vila
    Aleix Prat
    Eleanor Apthorp
    Alessandra Gennari
    David J. Pinato
    British Journal of Cancer, 2022, 127 : 1787 - 1792
  • [43] Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients
    Hasmann, Sandra
    Paal, Michael
    Fueessl, Louise
    Fischereder, Michael
    Schoenermarck, Ulf
    LANCET REGIONAL HEALTH-EUROPE, 2021, 10
  • [44] Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
    Cortellini, Alessio
    Aguilar-Company, Juan
    Salazar, Ramon
    Bower, Mark
    Sita-Lumsden, Ailsa
    Plaja, Andrea
    Lee, Alvin J. X.
    Bertuzzi, Alexia
    Tondini, Carlo
    Diamantis, Nikolaos
    Martinez-Vila, Clara
    Prat, Aleix
    Apthorp, Eleanor
    Gennari, Alessandra
    Pinato, David J.
    BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1787 - 1792
  • [45] Efficacy of Tixagevimab and Cilgavimab Against SARS-CoV-2 Infections in Patients with Inborn Errors of Immunity
    Johnson, Sarah
    McDonnell, John C.
    Fernandez, James M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (05) : 865 - 868
  • [46] Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective
    Hammarstrom, Lennart
    Abolhassani, Hassan
    Baldanti, Fausto
    Marcotte, Harold
    Pan-Hammarstrom, Qiang
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (01) : 58 - 60
  • [47] Efficacy of Tixagevimab and Cilgavimab Against SARS-CoV-2 Infections in Patients with Inborn Errors of Immunity
    Sarah Johnson
    John C. McDonnell
    James M. Fernandez
    Journal of Clinical Immunology, 2023, 43 (5) : 865 - 868
  • [48] Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 Infection
    Pathakumari, Balaji
    Marty, Paige K.
    Shah, Maleeha
    Van Keulen, Virginia P.
    Erskine, Courtney L.
    Block, Matthew S.
    Arias-Sanchez, Pedro
    Escalante, Patricio
    Peikert, Tobias
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [49] Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
    Wei, Xiaohui
    Rong, Na
    Liu, Jiangning
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines
    Manners, Christopher
    Bautista, Erick Larios
    Sidoti, Hannah
    Lopez, Osvaldo J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
12345